Key words: Coronary artery disease, angina pectoris, laser, myocardial revascularization
Twenty patients who had coronary arterial disease underwent PTA in preparation for myocardial revascularization
using the internal mammary artery.
associate professor of cardiology at Uppsala University Hospital in Uppsala, Sweden, and a member of the ESC Guidelines task force for myocardial revascularization
, commented on the update, stating, "The overall aim of the new guidelines for both percutaneous and surgical revascularization has been to shift emphasis from using primarily the anatomical expression of coronary artery disease to guide treatment toward a more patient oriented perspective, where all aspects of the disease are taken into account.
The combination of CD133+ stem cell transplantation and surgical myocardial revascularization
promises to be a new and enhanced causal therapy of severe ischemic cardiomyopathy," stated Dr.
They cover epidemiology, pathophysiology, clinical aspects, investigation, special groups of patients, pharmacological treatment, myocardial revascularization
, therapeutic strategy, and secondary prevention.
Angiogenesis and direct myocardial revascularization
The guidelines, issued last spring, specify that an invasive strategy with routine early coronary angiography and myocardial revascularization
as indicated, is clearly preferable only in the relatively small proportion of unstable angina patients deemed at high risk of death due to their coronary disease, In those at moderate risk--a category embracing the majority of patients with unstable acute coronary syndromes--or at low risk, the guidelines state that either an invasive or a conservative approach is appropriate.
Off-pump LVAD Supported Myocardial Revascularization
During Post Infarct Cardiogenic Shock (CS)," by Dr.
a medical device company engaged in the development and commercialization of the mesh based MGuard(TM) stent systems, is proud to report that mesh-based protection, is now recommended for use in the new Guidelines of the Task force of Myocardial Revascularization
of the European Society of Cardiology (ESC).
Pravastatin is also indicated to reduce the risk of myocardial infarction, reduce the risk of undergoing myocardial revascularization
procedures and reduce the risk of cardiovascular mortality with no increase in death from non-cardiovascular causes.
Bristol-Myers Squibb (BMS), which markets pravastatin as Pravachol, filed for approval of the copackaged product specifically for "long-term management to reduce the risk of death, nonfatal myocardial infarction, myocardial revascularization
procedures, and ischemic stroke in patients with clinically evident coronary heart disease.
OrthoLogic's product development pipeline also includes Chrysalin-based product candidates for dental bone formation and myocardial revascularization